VBIV logo

VBI Vaccines, Inc. New Common Stock (Canada)


VBIV: VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.


Show VBIV Financials

Consumer Interest
SEC Filings

Recent trades of VBIV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VBIV's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard

Number of mentions of VBIV in WallStreetBets Daily Discussion


Recent insights relating to VBIV

CNBC Recommendations

Recent picks made for VBIV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VBIV

Corporate Flights

Flights by private jets registered to VBIV